D-0352-2026 Class II Ongoing
FDA drug recall D-0352-2026 was initiated by Wizcure Pharmaa Private Limited on Dec 31, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. The recall status is ongoing. Affected quantity: 184,320 containers.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 4, 2026
- Initiation Date
- Dec 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 184,320 containers
Product description
BioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manufactured by Omni Lens PVT. Ltd., 5 - Samrudhhi, Opp. Sakar-III, Navrangpura, Ahmedabad, Gujarat, India - 380014, Email:info@omnilens.in, Manufactured for & disibruted by: HUB Pharmaceuticals, LLC, 8767 E Via de Ventura #175, Scottsdale, AZ, 85258, NDC 17238-900-11.
Reason for recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Distribution pattern
Distributed Nationwide in the USA
Code information
All lots
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0352-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026